Introduction
In Malawi, Acquired Immunodeficiency Syndrome (AIDS) is a major cause of death among 15 -49 year olds. It is estimated that 900,000 adults and children live with HIV/AIDS in Malawi, a country where the HIV/AIDS prevalence in adults (15-49 years) was 14.1% in 2005 1, 2 .In 2005, an estimated 170,000 people were in immediate need of antiretroviral therapy (ART) with children below 15 years accounting for nearly 15% of the those needing ART in Malawi . The COE is part of a network of clinics established by the Baylor International Paediatric AIDS Initiative (BIPAI) whose headquarters is in Houston, Texas, United States of America. The BIPAI network comprises of centres of excellence in Romania, Botswana, Lesotho, Uganda, Swaziland, and Malawi that provide care and treatment to HIV-infected children and families who qualify to be enrolled in the family clinic. Two additional centres of excellence are in the processes of being established in Kenya and Burkina Faso. BIPAI is also working with partners in Libya and Tanzania. The Malawi COE is located within the grounds of Kamuzu Central Hospital (KCH), a government facility in Lilongwe. The COE was officially opened on 2nd November, 2006. The COE is operated by a locally registered trust known as Baylor College of Medicine Children's Foundation -Malawi.
Patient care and training
The clinical and training functions of the programme are categorized into five levels: 1) patient care and training activities at the COE; 2) patient care at outreach sites in Lilongwe district; 3) patient care, training and supervision at outreach sites in all the other districts in the central region of Malawi; 4) patient care, training and supervision at distant sites in the southern and northern regions of Malawi; and 5) participation in national policy-level activities pertaining to paediatric HIV care. In addition to the comprehensive care and treatment provided to paediatric patients at the COE, a family clinic has been established whereby the HIV-infected child is the point of entry into the programme for the entire family. In the family clinic, HIV-infected adults and siblings of the index child also access care at the COE. All HIVinfected and HIVexposed children are routinely p r e s c r i b e d cotrimoxazole on monthly basis, provided with an insecticide-treated net, and a tablet splitter or pill cutter since a fixeddose combination ( T r i o m u n e : S t a v u d i n e , Lamivudine & Niverapine) is the most commonly prescribed antiretroviral for paediatric patients in Malawi. A few patients are on antiretroviral syrup formulations mainly second line regimens, courtesy of the Clinton Foundation. pertinent to paediatric HIV is held at a district level. A series of follow-up visits to ARV sites in each district are carried out, during which Baylor clinicians carry out practical in-clinic sessions on direct patient care. In Lilongwe district, outreach sites have been established at six national ART sites where Baylor clinicians provide HIV care and treatment services and mentor clinical staff at these sites. Clinical officers from district health centres where training has been conducted spend a week-long attachment at the COE. Attachments to the COE, enhances visiting clinicians self efficacy and experience.
Counselling, testing, and inpatient care
HIV/AIDS testing and counselling (HTC) is one of the key entry points into the programme. The COE and Lighthouse Trust HTC counselors work jointly operating from the KCH paediatric ward, serving both in-patients and out-patients. This has resulted in a reduction in missed opportunities for early identification of HIV-infected children. The COE is physically attached to KCH paediatric ward this ensures timely identification and enrolment of both HIV-exposed and HIV-infected children. Every effort is made not to offer HTC to potential COE patients especially those who are admitted to the Nutritional Rehabilitation Unit (NRU) at KCH. The COE staff in the paediatric ward consists of two paediatricians and a nurse who work hand in hand with KCH staff on daily basis to provide comprehensive paediatric care to both HIV-infected and uninfected children in the ward. The COE is also a recognized outpatient therapeutic programme (OTP) site for the management of moderately malnourished HIV-infected children. CD4+ cell counts are measured for all HIV infected patients every six months while only those who are suspected of treatment failure have their viral loads measured.
Methods
The programme utilizes multiple data collection methods, primarily an electronic medical records (EMR) system. Data were also collected from the following registers; daily patient attendance register, new patients register, ARV register, OTP programme (Nutrition) register, and social worker home visits (intensive follow up) register.
An evaluation of the programme was carried out in September 2007, that utilized two approaches: a two group non-randomized pretest post-test (case-control ) to assess medical records of paediatric patients, and a cross-sectional study to asses the level of satisfaction with services provided from a sample of programme users (caregivers and patients) and programme staff (providers). Electronic medical records of 129 patients on ARVs and 129 not on ARVs without identifiers were reviewed. The evaluation was based on data collected from the beginning of the programme in October 2004 to June 30, 2007. Selection of the medical records for retrospective review was based on ARV status (either on ARVs or not on ARVs). The patients were those registered by December 31, 2006 and still active by June 30, 2007 to ensure that each patient had data for at least six months. Two hundred and twenty-two caregivers (programme users) and twenty-one programme staff (providers) participated in face-to-face interviews to gather information on programme delivery. Consent was obtained and interviews conducted primarily in Chichewa among the caregivers although English was used in some cases depending on the literacy level of the caregiver. The evaluation study was approved by both the Malawi National Health Sciences Research Committee (NHSRC) and the Baylor College of Medicine institutional review board. Data were collected during August and September 2007 then analyzed in stages starting with descriptive statistics to more advanced procedures. The Chisquare and Fisher's exact tests were used to characterize the study population. Odds Ratios (OR) were calculated where possible to illustrate the strength of association. Weight-forheight-and-age percentiles were calculated using Epi-Info 2000 and World Health Organization reference growth charts (WHO 1978 reference). Stata software version 9.0 (College station, Texas, USA) was the principal statistical package used for data analyses. P-value and 95% confidence interval were used to determine levels of significance. A p-value of < 0.05 was considered statistically significant. Over half (58.1%) the patients were considered active since they had attended at least one clinic visit in the preceding six months, 17.7% were lost to follow up, 10.5% have died, 10.6% transferred out, and 3.1% had their files closed after ascertainment of HIV-negative status among HIV-exposed infants. Over 80% of patients reported as "lost to followup" had not been started on ARVs at the time they stopped accessing care. Since the start of the programme in 2004, a total of 202 infants and children had died with a majority of the deaths occurring during the first three months of enrolment into the programme. Patients aged below five years contributed to nearly three-quarters of the total deaths. The majority of deaths among the patients on ARVs occurred during the first three months of enrolment. Only three patients have been stopped from receiving ARVs due to poor adherence; none have been discontinued due to adverse effects of ARVs. The median follow up time on ARVs at the COE was 42 weeks, range (0 -136 weeks).
Results

Description of the cohort
Only thirty-nine patients had viral loads done by June 2007 due to suspected immunologic failure of whom twentyfive of them had detectable viral load (>400 copies/ml) and fourteen had undetectable viral load (<400 copies/ ml). A total of fifty patients had been switched from the standard first-line regimen in Malawi (Triomune: Stavudine, Lamivudine & Niverapine) to either an alternative first-line (22 patients) or a second line (28 patients) regimen. Main reasons for change of ART regimen to alternative first-line were hypersensitivity to Niverapine, peripheral neuropathy, and pancreatitis. Table 2 summarizes the comparison of the two groups on key demographic and clinical characteristics. A total of 258 medical records were reviewed; 129 on ARVs and 129 not on ARVs. Mean age at enrolment in each of the two groups was 4.8 years. The proportion of males among those on ARVs (59%) was significantly higher than among those not on ARVs (36%), and males were 2.6 times more likely to be on ARVs compared to females (p<0.05). Patients who had a confirmed HIV-positive diagnosis at enrolment were 2.5 times more likely to have been on ARVs compared to those who were HIV-exposed at enrolment (p<0.05). Patients in either WHO stage III or IV at enrolment were 11.1 times more likely to be on ARVs compared to those in either WHO stage I or II (p<0.05). Presence of malnutrition was more pronounced among those on ARVs. Baseline absolute CD4+ cell count and percent was significantly lower (about half) among patients on ARVs compared to those not on ARVs (p<0.05). Both the mean absolute CD4+ and percent doubled from 562 to 1280 cells/mm 3 and 14% to 28% respectively in nearly thirty months (p<0.05) among patients on ARVs.
Comparison by ARV status
Interviews
Nearly 90% of the caregivers (programme users) were females, and 65% of the caregivers were the reported biological mother of the child/patient. Other caregivers included aunts (12.6%), fathers (5.9%), grandmothers (5%), and sisters (4%). About half of the caregivers either had no formal schooling or only primary level education. Only about half of the caregivers were employed (full time or self employment) while 42.3% were unemployed. Table 3 shows that the level of satisfaction of services offered by the programme as reported by programme users and the providers. The programme users reported being very satisfied while the providers reported being satisfied with the services provided. None of the respondents reported being either unsatisfied or very unsatisfied with the programme.
Discussion
The new paediatric clinic facility has not only increased the ability of the staff to attend to more patients, but has also provided an environment conducive to providing optimal paediatric HIV care as well as training of health care personnel of different cadres on paediatric HIV/ AIDS. Laboratory services that include CD4+ cell count, HIV RNA measurements and chemistries are provided by Outcomes of this programme indicate that there is a clear benefit of providing ARVs to HIV-infected children. The baseline mean absolute CD4+ and percent nearly doubled from 562 to 1280 cells/mm 3 and 14% to 28% respectively in period of about two years. It was however not possible to explore the temporal relationship between immunologic changes (laboratory data) and clinical outcomes since we could not clearly link the laboratory dates to specific clinic visits such as 6th month, 12th month, 18th month visit and so on. Furthermore, only thirty-nine patients were referred for viral load testing suggesting that CD4 cell monitoring is an effective tool of monitoring ART in children. The early mortality (first three months) reported in this study is in agreement with findings from a study on risk factors for early mortality in children on fixed-dose combination ART reported from Malawi 6 . Early identification and prompt management of HIV-infected children is key to reducing early mortality. In a study carried out in the Southern part of Malawi, Zachariah et.al 7 concluded that community support might be associated with a considerably low death rate and overall better ART outcomes. An extension of the Baylor programme towards provision of community support may help reduce the early mortality in a similar manner.
The success of this programme in Malawi, and similar programmes sponsored by BIPAI in eight African countries has demonstrated that ART can be administered safely and effectively in developing countries. The expertise provided by the multidisciplinary programme staff, dedication shown by the caregivers and the continued support by programme partners has ensured that the programme continues to grow and provide hope to HIV-infected and HIV-exposed Malawian children. This programme is a testimony of reduction in stigma and discrimination associated with HIV/AIDS in Malawi, as evidenced by the fact that hundreds of patients accessing services from a facility that is publicly known to be dedicated to paediatric HIV care. This programme has demonstrated that ART can be administered safely and effectively to children, and provides a forum for more elaborate and sustained response to paediatric HIV/ AIDS care in Malawi.
